FDA Inspection 697933 — ImpactLife
The FDA completed an inspection of ImpactLife on Nov 17, 2010 in Ottumwa, IA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 17, 2010
- Fiscal Year
- 2011
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Ottumwa, IA (United States)